[EN] NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME<br/>[FR] ACTIVATEURS DE NLRP3 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES INFECTIEUSES OU DU CANCER PAR ACTIVATION DE L'INFLAMMASOME NLRP3
申请人:UNIV FREIBURG ALBERT LUDWIGS
公开号:WO2022079246A1
公开(公告)日:2022-04-21
The present invention relates to a compound or pharmaceutically acceceptable salts thereof, that modulates NLRP3 in that the NLRP3 inflammasome is activated. This invention further relates to the compounds and/or compositions for use in the prevention and treatment of a condition, disease or a disorder by activating the NLRP3 inflammasome, wherein the disease is selected from a group comprising infectious diseases, or cancer. Moreover, the invention relates to the use of the present compounds for analyzing the activity of NLRP3 activation.
本发明涉及一种化合物或其药学上可接受的盐,该化合物调节NLRP3,使NLRP3炎症小体被激活。本发明还涉及用于预防和治疗通过激活NLRP3炎症小体的疾病、疾病或障碍的化合物和/或组合物,其中该疾病选自感染性疾病或癌症等一组疾病。此外,本发明还涉及使用本化合物分析NLRP3激活的活性。